|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Interest income | ||
| Interest expense | ||
| Other expense, net | ||
| Total other income, net | ||
| Net loss | ||
| Other comprehensive income | ||
| Unrealized gain (loss) on available-for-sale marketable securities, net | ||
| Total other comprehensive gain (loss) | ||
| Net loss and other comprehensive loss | ||
| Net loss per share attributable to common stockholders, basic | ||
| Net loss per share attributable to common stockholders, diluted | ||
| Weighted-average shares of common stock outstanding, basic | ||
| Weighted-average shares of common stock outstanding, diluted |
Loading...
